After this program, participants will be able to:
1.  Identify available CGM devices and interpret Ambulatory Glucose Profile (AGP) reports to support clinical decision-making.

2. Apply CGM data to optimize nutrition counselling, insulin management, and individualized diabetes care.

3. Apply evidence-based approaches to identify individuals at risk for type 1 diabetes and implement appropriate screening and monitoring strategies.

4. Implement best practices for CGM adoption, injection techniques, the prevention and management of diabetes-related wounds, and the integration of emerging diabetes technologies into clinical practice.